Ihsan Gursel

Ihsan Gursel

Auto-generated profile, based on publicly available information

Ihsan Gursel

Izmir Biomedicine and Genome Center, DEU Saglik Kampusu, Balcova, Turkey

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2001 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
FTFumihiko Takeshita
Fumihiko Takeshita
CLCynthia A Leifer
Cynthia A Leifer
IGIhsan Gursel
Ihsan Gursel
KIKen Ishii
Ken Ishii
STSaoko Takeshita
Saoko Takeshita
DKDennis M. Klinman
Dennis M. Klinman
Unmethylated CpG motifs present in bacterial DNA stimulate a rapid and robust innate immune response. Human cell lines and PBMC that recognize CpG DNA express membrane-bound human Toll-like receptor 9 (hTLR9). Cells that are not responsive to CpG DNA become responsive when transfected with hTLR9. Expression of hTLR9 dramatically increases uptake of CpG (but not control) DNA into endocytic vesicles. Upon cell stimulation, hTLR9 and CpG DNA are found in the same endocytic vesicles. Cells expressing hTLR9 are stimulated by CpG motifs that are active in primates but not rodents, suggesting that evolutionary divergence between TLR9 molecules underlies species-specific differences in the recognition of bacterial DNA. These findings indicate that hTLR9 plays a critical role in the CpG DNA-mediated activation of human cells.

5 May 2004 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
DKDennis M. Klinman
Dennis M. Klinman
DCDebra Currie
Debra Currie
IGIhsan Gursel
Ihsan Gursel
DVDaniela Verthelyi
Daniela Verthelyi

1 August 2003 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
IGIhsan Gursel
Ihsan Gursel
MGMayda Gursel
Mayda Gursel
HYHiroshi Yamada
Hiroshi Yamada
KIKen Ishii
Ken Ishii
FTFumihiko Takeshita
Fumihiko Takeshita
DKDennis M. Klinman
Dennis M. Klinman
Bacterial DNA contains immunostimulatory CpG motifs that trigger an innate immune response capable of promoting host survival following infectious challenge. Yet CpG-driven immune activation may also have deleterious consequences, ranging from autoimmune disease to death. We find that repetitive elements present at high frequency in mammalian telomeres, but rare in bacteria, down-regulate CpG-induced immune activation. Suppressive activity correlates with the ability of telomeric TTAGGG repeats to form G-tetrads. Colocalization of CpG DNA with Toll-like receptor 9 in endosomal vesicles is disrupted by these repetitive elements, although cellular binding and uptake remain unchanged. These findings are the first to establish that specific host-derived molecules can down-regulate the innate immune response elicited by a TLR ligand.

1 May 1999 in Journal of Controlled Release
Verified
Journal Article
Closed access
DSDilek Sendil
Dilek Sendil
IGIhsan Gürsel
Ihsan Gürsel
DWDonald L. Wise
Donald L. Wise
VHVasıf Hasırcı
Vasıf Hasırcı

1 May 2002 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
MGMayda Gursel
Mayda Gursel
DVDaniela Verthelyi
Daniela Verthelyi
IGIhsan Gürsel
Ihsan Gürsel
KIKen Ishii
Ken Ishii
DKDennis M Klinman
Dennis M Klinman
Synthetic oligodeoxynucleotides (ODN) expressing “CpG motifs” show promise as immune adjuvants, antiallergens, anticancer, and immunoprotective agents. Two structurally distinct classes of CpG ODN have been identified that stimulate human PBMC. This work establishes that both types of ODN bind to and are internalized by the same individual B cells, NK cells, and monocytes. However, the intracellular localization of “D” and “K” ODN differs, as does their functional activity: “K” type ODN trigger monocytes and B cells to proliferate and secrete IL-6 and IgM, whereas “D” type ODN induce NK cells to produce IFN-γ and monocytes to differentiate into CD83+/CD86+ dendritic cells. In monocytes, these two types of ODN (which differ in backbone composition and CpG motif) cross-inhibit one another's activity. Thus, different types of CpG ODN have distinct and in some cases incompatible effects on the same cells, a finding with important implications for the therapeutic use of these agents.

1 February 2004 in Seminars in Immunology
Verified
Journal Article
Closed access
FTFumihiko Takeshita
Fumihiko Takeshita
IGIhsan Gursel
Ihsan Gursel
KIKen Ishii
Ken Ishii
KSKoichi Suzuki
Koichi Suzuki
MGMayda Gursel
Mayda Gursel
DKDennis M. Klinman
Dennis M. Klinman